Sustained type I interferon activity and N-antigenemia form a vicious cycle during severe COVID-19.

Mouton W, Saker K, Franc P, Mommert-Tripon M, Oriol G, Generenaz L, Cheynet V, Bal A, Pons L, Wittmann B, Bussy D, Bastard P, Casanova JL, Sebai S, Chebel A, Chatonnet F, Costagliola D, Arribas J, Viermyr HK, Poissy J, Holten AR, Baldé A, Roux E, Olsen IC, Brengel-Pesce K, Pons S, Barnel C, Mokdad B, Wallet F, Genestier L, Terrier O, Trøseid M, Richard JC, Trouillet-Assant S, Interfericus and BarisolidAct study groups

Open source

DOI
10.1016/j.ebiom.2026.106508
Published
2026 Oct 12
Container
EBioMedicine
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ebiom.2026.106508,
  title = {Sustained type I interferon activity and N-antigenemia form a vicious cycle during severe COVID-19.},
  author = {Mouton W and Saker K and Franc P and Mommert-Tripon M and Oriol G and Generenaz L and Cheynet V and Bal A and Pons L and Wittmann B and Bussy D and Bastard P and Casanova JL and Sebai S and Chebel A and Chatonnet F and Costagliola D and Arribas J and Viermyr HK and Poissy J and Holten AR and Baldé A and Roux E and Olsen IC and Brengel-Pesce K and Pons S and Barnel C and Mokdad B and Wallet F and Genestier L and Terrier O and Trøseid M and Richard JC and Trouillet-Assant S and Interfericus and BarisolidAct study groups},
  year = {2026},
  journal = {EBioMedicine},
  doi = {10.1016/j.ebiom.2026.106508},
  url = {https://doi.org/10.1016/j.ebiom.2026.106508}
}

RIS

TY  - JOUR
TI  - Sustained type I interferon activity and N-antigenemia form a vicious cycle during severe COVID-19.
AU  - Mouton W
AU  - Saker K
AU  - Franc P
AU  - Mommert-Tripon M
AU  - Oriol G
AU  - Generenaz L
AU  - Cheynet V
AU  - Bal A
AU  - Pons L
AU  - Wittmann B
AU  - Bussy D
AU  - Bastard P
AU  - Casanova JL
AU  - Sebai S
AU  - Chebel A
AU  - Chatonnet F
AU  - Costagliola D
AU  - Arribas J
AU  - Viermyr HK
AU  - Poissy J
AU  - Holten AR
AU  - Baldé A
AU  - Roux E
AU  - Olsen IC
AU  - Brengel-Pesce K
AU  - Pons S
AU  - Barnel C
AU  - Mokdad B
AU  - Wallet F
AU  - Genestier L
AU  - Terrier O
AU  - Trøseid M
AU  - Richard JC
AU  - Trouillet-Assant S
AU  - Interfericus and BarisolidAct study groups
PY  - 2026
JO  - EBioMedicine
DO  - 10.1016/j.ebiom.2026.106508
UR  - https://doi.org/10.1016/j.ebiom.2026.106508
ER  -

APA

W, M., K, S., P, F., M, M., G, O., L, G., V, C., A, B., L, P., B, W., D, B., P, B., JL, C., S, S., A, C., F, C., D, C., J, A., HK, V., J, P., AR, H., A, B., E, R., IC, O., K, B., S, P., C, B., B, M., F, W., L, G., O, T., M, T., JC, R., S, T., & groups, I. A. B. S. (2026). Sustained type I interferon activity and N-antigenemia form a vicious cycle during severe COVID-19.. EBioMedicine. https://doi.org/10.1016/j.ebiom.2026.106508

Source records